New onset of generalized myasthenia gravis developed after a new coronavirus infection (COVID-19)

Abstract

Development of various immune-mediated neurological complications after a viral infection is of particular interest to medical society during a pandemic of COVID-19. It was found that SARS-CoV-2 has the ability to cause hyperstimulation of the immune system, thereby initiating developing of autoimmune diseases. The article describes a clinical case of new onset of generalized myasthenia gravis with thymoma in a patient after previous COVID-19.

Keywords

• myasthenia gravis
• new coronavirus infection
• covid-19
• sars-cov-2
• thymoma
• autoimmune diseases